SB 256STATE · New HampshireIntroduced

establishing safety and care requirements for clinician-administered drugs.

Latest action: Refer for Interim Study: MA VV 05/14/2026 HJ 13 P. 2

Voted: 5/14/2026Source

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

4/22/2026Executive Session: 04/29/2026 10:00 am GP 229
4/16/2026Subcommittee Work Session: 04/22/2026 10:00 am GP 229
4/2/2026Public Hearing: 04/07/2026 02:15 pm GP 159
4/1/2026Subcommittee Work Session: 04/08/2026 10:00 am GP 229
3/2/2026Vacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt): MA VV (in recess of) 02/19/2026 HJ 5
2/26/2026Introduced (in recess of) 02/19/2026 and referred to Health, Human Services and Elderly Affairs HJ 5
1/7/2026Committee Amendment # 2025-3029s, AA, VV; 01/07/2026; SJ 1
1/7/2026Ought to Pass with Amendment #2025-3029s, MA, VV; OT3rdg; 01/07/2026; SJ 1
10/22/2025Committee Report: Ought to Pass with Amendment # 2025-3029s, 01/07/2026; Vote 5-0; CC; SC 46
3/6/2025Rereferred to Committee, MA, VV; 03/06/2025; SJ 6